GSK Consumer Healthcare buys Elan's dermatology products

Published: 3-Jan-2003

GlaxoSmithKline Consumer Healthcare, a division of GlaxoSmithKline Corporation, has obtained five dermatology products from Elan Pharmaceuticals, which is withdrawing from the dermatology business.


GlaxoSmithKline Consumer Healthcare, a division of GlaxoSmithKline Corporation, has obtained five dermatology products from Elan Pharmaceuticals, which is withdrawing from the dermatology business.

As from the beginning of the year, GSK Consumer Healthcare is marketing Aclovate, Cutivate, Temovate, Oxistat and Emgel.

'These pharmaceutical products are an excellent fit with our otc brands, including Oxy acne products and Abreva cold sore medication,' said Manfred Scheske, president, GSK Consumer Healthcare North America.

According to Elan, the five products generated revenues of US$62m (€60m) in 2001.

You may also like